Abstract
Tumor Cell Panel with Characterized Expression of PD-L1 for Preclinical Studies of Anticancer Drugs and Immune Checkpoint Inhibitors’ Interaction
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have